Ftse Mib
32.573,67
-3,08%
DAX
17.975,91
-1,58%
S&P 500
5.418,87
-0,27%
NASDAQ
17.648,63
-0,11%
Bitcoin
66.847,85
0,14%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Seres Therapeutics Inc (MCRB) Seres Therapeutics Inc (MCRB) Notizie

Seres Therapeutics Inc

MCRB
0,6995
-0,0109 (-1,53%)
Ultimo aggiornamento: 17:10:32
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/6/202422:00GLOBESeres Therapeutics Reports Inducement Grants Under Nasdaq..
06/6/202413:00PRNUSNestlé Health Science agrees to acquire global rights to..
06/6/202412:30GLOBESeres Therapeutics Enters Into Memorandum of Understanding..
18/5/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202416:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:05EDGAR2Form 8-K - Current report
08/5/202413:00BWSeres Therapeutics Reports First Quarter 2024 Financial..
07/5/202423:18EDGAR2Form 8-K - Current report
06/5/202422:01BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
06/5/202415:30BWSeres Therapeutics to Announce First Quarter 2024 Financial..
09/4/202413:00BWSeres Therapeutics Announces Completion of Patient..
28/3/202412:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
19/3/202412:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
05/3/202416:18EDGAR2Form DEF 14A - Other definitive proxy statements
05/3/202416:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202413:05EDGAR2Form 8-K - Current report
05/3/202413:00BWSeres Therapeutics Reports Fourth Quarter and Full Year 2023..
05/3/202412:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
28/2/202413:00BWSeres Therapeutics to Host Fourth Quarter 2023 Financial..
27/2/202413:00BWSeres Therapeutics to Participate in Cowen 44th Annual..
26/2/202413:06EDGAR2Form 8-K - Current report
26/2/202413:00BWSeres Therapeutics Announces the Appointment of Marella..
23/2/202422:05EDGAR2Form PRE 14A - Other preliminary proxy statements
17/2/202403:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202403:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202422:01EDGAR2Form 8-K - Current report
17/1/202413:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
10/1/202413:00EDGAR2Form 8-K - Current report
09/1/202414:10DJNSeres Therapeutics Shares Rise 15% After Getting FDA..
09/1/202413:05EDGAR2Form 8-K - Current report
09/1/202413:00BWSeres Therapeutics Announces VOWST™ Commercial Launch Update..
04/1/202422:00BWSeres Therapeutics to Participate in the 42nd Annual J.P...
02/1/202422:05EDGAR2Form 8-K - Current report
08/12/202301:46BWSeres Therapeutics Announces Presentation of Preliminary..
28/11/202315:18BWSeres Therapeutics to Participate in the Piper Sandler 35th..
28/11/202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202312:05EDGAR2Form 8-K - Current report
02/11/202312:00BWSeres Therapeutics Reports Third Quarter 2023 Financial..
01/11/202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
01/11/202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,7106 Min: 0,69 Max: 0,7335
Chiusura: 0,7104

La tua Cronologia

NASDAQ
MCRB
Seres Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network